ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate : A sulfonamide in which the nitrogen carries methyl and 2-[4-(ethoxycarbonyl)piperazin-1-yl]-2-oxoethyl substituents and the sulfonyl a 4-chlorophenyl group.
ID Source | ID |
---|---|
PubMed CID | 1073012 |
CHEMBL ID | 1422244 |
CHEBI ID | 131996 |
Synonym |
---|
AKOS000432010 |
ethyl 4-[n-(4-chlorobenzene-1-sulfonyl)-n-methylglycyl]piperazine-1-carboxylate |
ethyl 4-[2-[[(4-chlorophenyl)sulfonyl]methylamino]acetyl]-1-piperazinecarboxylate |
CHEBI:131996 |
4-[2-[[(4-chlorophenyl)sulfonyl]methylamino]acetyl]-1-piperazinecarboxylic acid, ethyl ester |
STK319217 |
ethyl 4-{n-[(4-chlorophenyl)sulfonyl]-n-methylglycyl}piperazine-1-carboxylate |
MLS001220111 , |
4-{2-[(4-chloro-benzenesulfonyl)-methyl-amino]-acetyl}-piperazine-1-carboxylic acid ethyl ester |
smr000611886 |
ethyl 4-[2-[(4-chlorophenyl)sulfonyl-methylamino]acetyl]piperazine-1-carboxylate |
VU0459162-1 |
HMS2916H06 |
CHEMBL1422244 |
4-[2-[(4-chlorophenyl)sulfonyl-methyl-amino]acetyl]piperazine-1-carboxylic acid ethyl ester |
cid_1073012 |
ethyl 4-[2-[(4-chlorophenyl)sulfonyl-methyl-amino]ethanoyl]piperazine-1-carboxylate |
bdbm84320 |
4-[2-[(4-chlorophenyl)sulfonyl-methylamino]-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester |
cambridge id 7042384 |
Z30614039 |
ethyl 4-(n-((4-chlorophenyl)sulfonyl)-n-methylglycyl)piperazine-1-carboxylate |
Q27225347 |
CS-0619794 |
HY-148361 |
fluorogen binding modulator-1 |
EX-A6525 |
way-323975 |
510716-65-1 |
Class | Description |
---|---|
sulfonamide | An amide of a sulfonic acid RS(=O)2NR'2. |
carbamate ester | Any ester of carbamic acid or its N-substituted derivatives. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 6.3096 | 5.6234 | 17.2929 | 31.6228 | AID485281 |
nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 1.8356 | 0.0041 | 9.9848 | 25.9290 | AID504444 |
DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 70.7946 | 0.0501 | 27.0736 | 89.1251 | AID588590 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
beta-2 adrenergic receptor | Homo sapiens (human) | EC50 (µMol) | 1.4683 | 0.0016 | 1.8759 | 8.4400 | AID588763; AID588775 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
AID1159537 | qHTS screening for TAG (triacylglycerol) accumulators in algae | 2017 | Plant physiology, Aug, Volume: 174, Issue:4 | Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
---|---|---|---|---|---|---|
levoplast | [no description available] | medium | 1 | 0 | C-nitro compound | |
hippuric acid | [no description available] | medium | 1 | 0 | N-acylglycine | human blood serum metabolite; uremic toxin |
xanthine | [no description available] | medium | 1 | 0 | xanthine | Saccharomyces cerevisiae metabolite |
atrolactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | |
etofylline | [no description available] | medium | 1 | 0 | oxopurine | |
n-acetyltryptophan | [no description available] | medium | 1 | 0 | N-acetyl-amino acid; tryptophan derivative | metabolite |
ethacridine | [no description available] | medium | 1 | 0 | acridines | |
altretamine | [no description available] | medium | 1 | 0 | triamino-1,3,5-triazine | |
2,5-di-tert-butylhydroquinone | [no description available] | medium | 1 | 0 | hydroquinones | |
cx546 | [no description available] | medium | 1 | 0 | ||
diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
diuron | [no description available] | medium | 1 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic |
ibuprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic |
ipriflavone | [no description available] | medium | 1 | 0 | aromatic ether; isoflavones | bone density conservation agent |
mebendazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator |
nocodazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester; thiophenes | antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator |
piribedil | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
prometone | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine; methoxy-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
propanil | [no description available] | medium | 1 | 0 | anilide; dichlorobenzene | herbicide |
sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
sulfamethazine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
sulfathiazole | [no description available] | medium | 1 | 0 | 1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
testosterone | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
2-hydroxybenzylbenzimidazole | [no description available] | medium | 1 | 0 | ||
etimizol | [no description available] | medium | 1 | 0 | ||
nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
bis(4-hydroxyphenyl)sulfone | [no description available] | medium | 1 | 0 | bisphenol; sulfone | endocrine disruptor; metabolite |
8-hydroxyquinoline-5-sulfonic acid | [no description available] | medium | 1 | 0 | ||
salicylanilide | [no description available] | medium | 1 | 0 | benzanilide fungicide; salicylamides; salicylanilides | |
2-phenylbutyric acid | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | human xenobiotic metabolite |
4,4'-dimethoxybenzophenone | [no description available] | medium | 1 | 0 | ||
6-phenyl-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | ||
quinaldic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | human metabolite; Saccharomyces cerevisiae metabolite |
N-(2-methoxyphenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; methoxybenzenes | |
fast red b | [no description available] | medium | 1 | 0 | ||
methylenebis(chloroaniline) | [no description available] | medium | 1 | 0 | chloroaniline | metabolite |
di-(4-aminophenyl)ether | [no description available] | medium | 1 | 0 | aromatic ether | |
diphenylguanidine | [no description available] | medium | 1 | 0 | guanidines | allergen |
4-Anilino-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
mephobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant |
etryptamine | [no description available] | medium | 1 | 0 | indoles | |
sulfacetamide | [no description available] | medium | 1 | 0 | ||
cinchophen | [no description available] | medium | 1 | 0 | quinolines | |
2-aminobenzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles | |
carzenide | [no description available] | medium | 1 | 0 | sulfonamide | |
nitrilotriacetic acid | [no description available] | medium | 1 | 0 | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent |
n-(2-cyanoethyl)-2-phenylethylamine | [no description available] | medium | 1 | 0 | ||
cyclooctane | [no description available] | medium | 1 | 0 | ||
triphenyltetrazolium chloride | [no description available] | medium | 1 | 0 | organic chloride salt | dye; indicator |
2,7-diacetylaminofluorene | [no description available] | medium | 1 | 0 | ||
3,4-pyridinedicarboxylic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | |
4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
tropic acid | [no description available] | medium | 1 | 0 | 3-hydroxy monocarboxylic acid | human xenobiotic metabolite |
8-hydroxy-7-iodo-5-quinolinesulfonic acid | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
1-acetylisatin | [no description available] | medium | 1 | 0 | indoledione | |
4-cumylphenol | [no description available] | medium | 1 | 0 | diarylmethane | |
5-methylisatin | [no description available] | medium | 1 | 0 | ||
2-hydrazinobenzothiazole | [no description available] | medium | 1 | 0 | ||
1,2,3-trimethoxybenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | plant metabolite |
2-amino-5-chlorobenzophenone | [no description available] | medium | 1 | 0 | ||
diphenamid | [no description available] | medium | 1 | 0 | diarylmethane | |
4-(4-nitrobenzyl)pyridine | [no description available] | medium | 1 | 0 | ||
5-methyl-3-phenylisoxazole-4-carboxylic acid | [no description available] | medium | 1 | 0 | ||
2-acetylbenzofuran | [no description available] | medium | 1 | 0 | ||
pyrazon | [no description available] | medium | 1 | 0 | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic |
2-amino-5-nitrobenzophenone | [no description available] | medium | 1 | 0 | ||
(4-tert-Butyl-phenoxy)-acetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
lenacil | [no description available] | medium | 1 | 0 | cyclopentapyrimidine | agrochemical; environmental contaminant; herbicide; xenobiotic |
chlordesmethyldiazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
2-amino-2',5-dichlorobenzophenone | [no description available] | medium | 1 | 0 | ||
2-(2'-hydroxyphenyl)benzimidazole | [no description available] | medium | 1 | 0 | ||
4-phthalimidobutyric acid | [no description available] | medium | 1 | 0 | ||
azabutyrone | [no description available] | medium | 1 | 0 | ||
2-(2-hydroxyphenyl)benzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles; phenols | geroprotector |
4,5-dichlorocatechol | [no description available] | medium | 1 | 0 | ||
n-butylbenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | neurotoxin; plant metabolite |
3-phenoxybenzoic acid | [no description available] | medium | 1 | 0 | phenoxybenzoic acid | human xenobiotic metabolite; marine xenobiotic metabolite |
2-(2-hydroxyethylmercapto)benzothiazole | [no description available] | medium | 1 | 0 | ||
carboxin | [no description available] | medium | 1 | 0 | anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
meturin | [no description available] | medium | 1 | 0 | ||
2-bromo-N-phenylbenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-chlorohippuric acid | [no description available] | medium | 1 | 0 | ||
4-chlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; monochlorobenzenes | phenoxy herbicide |
2,5-dichloro-1,4-phenylenediamine | [no description available] | medium | 1 | 0 | ||
metribuzin | [no description available] | medium | 1 | 0 | 1,2,4-triazines; cyclic ketone; organic sulfide | agrochemical; environmental contaminant; herbicide; xenobiotic |
2,5-dimethyl-3-furancarboxanilide | [no description available] | medium | 1 | 0 | ||
moricizine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
2-benzimidazolylguanidine | [no description available] | medium | 1 | 0 | aminoimidazole | |
diflubenzuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide; monochlorobenzenes | insect sterilant |
pentafluorobenzoyl-n-phenylethylamine | [no description available] | medium | 1 | 0 | ||
thidiazuron | [no description available] | medium | 1 | 0 | ureas | |
phenthiazamine | [no description available] | medium | 1 | 0 | ||
5,5-diphenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
3-acetamidobenzoic acid | [no description available] | medium | 1 | 0 | ||
dazoxiben hydrochloride | [no description available] | medium | 1 | 0 | ||
succinylsulfanilamide | [no description available] | medium | 1 | 0 | ||
benzylaminopurine | [no description available] | medium | 1 | 0 | 6-aminopurines | cytokinin; plant metabolite |
ciprofloxacin hydrochloride anhydrous | [no description available] | medium | 1 | 0 | hydrochloride | antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
src-820 r | [no description available] | medium | 1 | 0 | ||
n(4)-acetylsulfadiazine | [no description available] | medium | 1 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
4-nitro-alpha-acetylamino-beta-hydroxypropiophenone | [no description available] | medium | 1 | 0 | ||
formetamide | [no description available] | medium | 1 | 0 | ||
isbufylline | [no description available] | medium | 1 | 0 | ||
phenylacetylglycine | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monocarboxylic acid; N-acylglycine | human metabolite; mouse metabolite |
N-benzoylanthranilic acid | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
butinoline | [no description available] | medium | 1 | 0 | diarylmethane | |
n-(2-carboxyphenyl)glycine | [no description available] | medium | 1 | 0 | ||
n,n-dimethyl-4-anisidine | [no description available] | medium | 1 | 0 | ||
n-benzoylpiperidine | [no description available] | medium | 1 | 0 | benzamides; N-acylpiperidine | |
2-phenylcyclopropanecarboxylic acid | [no description available] | medium | 1 | 0 | ||
n-demethylantipyrine | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | [no description available] | medium | 1 | 0 | 1,2,4-triazines | |
2-amino-5-bromopyridine | [no description available] | medium | 1 | 0 | ||
n-benzoylalanine, (dl-ala)-isomer | [no description available] | medium | 1 | 0 | alanine derivative; N-acyl-amino acid | metabolite |
bicinchoninic acid | [no description available] | medium | 1 | 0 | ||
betamipron | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
benzoylpropionic acid | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid | hapten |
Evoxine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | harmala alkaloid | |
N-Benzylphthalimide | [no description available] | medium | 1 | 0 | isoindoles | |
pyromellitic diimide | [no description available] | medium | 1 | 0 | ||
4'-bromosalicylanilide | [no description available] | medium | 1 | 0 | ||
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | [no description available] | medium | 1 | 0 | bisphenol | |
terephthalamide | [no description available] | medium | 1 | 0 | benzenedicarboxamide | |
3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl- | [no description available] | medium | 1 | 0 | ||
2-nitrophenylacetic acid | [no description available] | medium | 1 | 0 | C-nitro compound; phenylacetic acids | |
onychine | [no description available] | medium | 1 | 0 | ||
4'-methoxyflavone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
1,3-diphenyl-2-aminopropane | [no description available] | medium | 1 | 0 | ||
2,2-diphenylpropionic acid | [no description available] | medium | 1 | 0 | ||
3,4-dimethoxyphenylacetamide | [no description available] | medium | 1 | 0 | ||
2-amino-5-bromobenzoic acid | [no description available] | medium | 1 | 0 | ||
2-(1H-benzimidazol-2-yl)aniline | [no description available] | medium | 1 | 0 | benzimidazoles; primary arylamine; substituted aniline | geroprotector |
N-Acetylhomoveratrylamine | [no description available] | medium | 1 | 0 | acetamides | |
2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
4-nitrophenyl dimethylcarbamate | [no description available] | medium | 1 | 0 | ||
8-(4-tolylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | sulfonamide | |
5-methoxyindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | indoles | |
2-oxo-1,2-dihydroquinoline-4-carboxylic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | |
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | [no description available] | medium | 1 | 0 | beta-carbolines | |
pd 147953 | [no description available] | medium | 1 | 0 | ||
fenozan | [no description available] | medium | 1 | 0 | ||
5-phenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
diethylpropion hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | appetite depressant |
1-(4'-nitrophenyl)-2-aminopropane-1,3-diol | [no description available] | medium | 1 | 0 | ||
beta-hydroxyphenylalanine | [no description available] | medium | 1 | 0 | ||
3-(n-salicyloyl)amino-1,2,4-triazole | [no description available] | medium | 1 | 0 | ||
7-chloro-4-aminoquinoline | [no description available] | medium | 1 | 0 | aminoquinoline | |
acridine-9-carboxylic acid | [no description available] | medium | 1 | 0 | ||
1-phenazinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; monocarboxylic acid; phenazines | antifungal agent; antimicrobial agent; bacterial metabolite |
4,5-diphenyl-1,5-dihydroimidazol-2-one | [no description available] | medium | 1 | 0 | stilbenoid | |
2-hydroxy-1,2-bis(methoxyphenyl)ethanone | [no description available] | medium | 1 | 0 | ||
4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-n-butylaminobenzoic acid | [no description available] | medium | 1 | 0 | aromatic amino acid | |
fluoren-9-ol | [no description available] | medium | 1 | 0 | ||
1-(2-carboxyethyl)uracil | [no description available] | medium | 1 | 0 | ||
1-benzylindole | [no description available] | medium | 1 | 0 | ||
2,3-bis(2-pyridinyl)quinoxaline | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | [no description available] | medium | 1 | 0 | dichlorobenzene; hydroxybiphenyls | |
5-nitro-2-(1-piperidinyl)pyridine | [no description available] | medium | 1 | 0 | C-nitro compound | |
2-amino-5,7-dimethyl-1,8-naphthyridine | [no description available] | medium | 1 | 0 | ||
5-benzyloxytryptophan | [no description available] | medium | 1 | 0 | ||
2,5-diethoxy-4-morpholinoaniline | [no description available] | medium | 1 | 0 | ||
3-hydroxy-3-phenacyloxindole | [no description available] | medium | 1 | 0 | ||
carbobenzoxyphenylalanine, (dl-phe)-isomer | [no description available] | medium | 1 | 0 | ||
gamma-fagarine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
3-carboxymethyl-6-benzyl-2,5-diketopiperazine | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
4-fluorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
emoxypine succinate | [no description available] | medium | 1 | 0 | ||
n-carbamyltryptophan | [no description available] | medium | 1 | 0 | ||
2,4,6-trimethoxyacetophenone | [no description available] | medium | 1 | 0 | ||
1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | [no description available] | medium | 1 | 0 | ||
4-methyoxybenzoyl-n-glycine | [no description available] | medium | 1 | 0 | N-acylglycine | |
5-ethoxy-2-ethylmercaptobenzimidazole | [no description available] | medium | 1 | 0 | ||
5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester | [no description available] | medium | 1 | 0 | ||
n-phenyliminodiacetic acid | [no description available] | medium | 1 | 0 | ||
teomorfolin | [no description available] | medium | 1 | 0 | ||
1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone | [no description available] | medium | 1 | 0 | benzodioxoles | |
n-(aminocarbonyl)-2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
3-hydroxy-2-quinoxalinepropionic acid | [no description available] | medium | 1 | 0 | ||
8-(methylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
n(4)-acetylsulfamonomethoxine | [no description available] | medium | 1 | 0 | ||
8-(4-benzenesulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
methindione | [no description available] | medium | 1 | 0 | ||
3,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | ||
gamma-propanol | [no description available] | medium | 1 | 0 | ||
2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile | [no description available] | medium | 1 | 0 | benzenes; nitrile | |
isonicotinylamide gaba | [no description available] | medium | 1 | 0 | ||
5-fluorotryptamine monohydrochloride | [no description available] | medium | 1 | 0 | ||
4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide | [no description available] | medium | 1 | 0 | ||
3-(hydroxyacetyl)indole | [no description available] | medium | 1 | 0 | indoles | |
n-(4-aminophenylsulfonyl)morpholine | [no description available] | medium | 1 | 0 | ||
1H-indol-3-yl-(4-methoxyphenyl)methanone | [no description available] | medium | 1 | 0 | N-acylindole | |
2-amino-5-phenyl-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | ||
N-(1-phenylethyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; secondary carboxamide | |
alpha-(trichloromethyl)-4-pyridineethanol | [no description available] | medium | 1 | 0 | pyridines | |
ml 204 | [no description available] | medium | 1 | 0 | ||
eudesmin | [no description available] | medium | 1 | 0 | ||
2-amino-4-methyl-3-nitropyridine | [no description available] | medium | 1 | 0 | ||
4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline | [no description available] | medium | 1 | 0 | ||
n-acetylhistidine | [no description available] | medium | 1 | 0 | histidine derivative; N-acetyl-amino acid | |
1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | [no description available] | medium | 1 | 0 | acetamides | |
1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
4-methoxyxanthone | [no description available] | medium | 1 | 0 | ||
N-(4-nitrophenyl)-2-phenoxyacetamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
1-phenylindolin-2-one | [no description available] | medium | 1 | 0 | ||
1-(benzenesulfonyl)indole | [no description available] | medium | 1 | 0 | sulfonamide | |
2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile | [no description available] | medium | 1 | 0 | dihydropyridine | |
pifithrin mu | [no description available] | medium | 1 | 0 | benzenes | |
2-benzyloxybenzaldehyde | [no description available] | medium | 1 | 0 | ||
2-guanidine-4-methylquinazoline | [no description available] | medium | 1 | 0 | ||
N-phenylcarbamic acid 2-phenoxyethyl ester | [no description available] | medium | 1 | 0 | carbamate ester | |
3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol | [no description available] | medium | 1 | 0 | benzimidazoles | |
mequindox | [no description available] | medium | 1 | 0 | ||
N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide | [no description available] | medium | 1 | 0 | diarylmethane | |
Girgensonine | [no description available] | medium | 1 | 0 | nitrile | |
Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
N-[4-(methanesulfonamido)phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-(2-oxazolo[4,5-b]pyridinyl)aniline | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole | [no description available] | medium | 1 | 0 | benzoxazole | |
3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium | [no description available] | medium | 1 | 0 | pyridazines | |
3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone | [no description available] | medium | 1 | 0 | substituted aniline | |
1-phenyl-4-pyrazolol | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | [no description available] | medium | 1 | 0 | benzothiazoles | |
3-benzamido-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
N-[2-(4-methoxyphenyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | acetamides | |
N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic ether | |
2-(1H-indol-3-ylthio)acetic acid | [no description available] | medium | 1 | 0 | indoles | |
3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
3-Methylbenzofuran-2-carboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
5-(3,4-dimethoxyphenyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | tetrazoles | |
1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
2-phenylindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | ||
4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide | |
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | [no description available] | medium | 1 | 0 | C-nitro compound | |
3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline | [no description available] | medium | 1 | 0 | pyrimidines | |
7-methoxyisoflavone | [no description available] | medium | 1 | 0 | 7-methoxyisoflavones | |
LSM-32392 | [no description available] | medium | 1 | 0 | monoterpenoid | |
N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-acetamido-5-chloro-2-benzofurancarboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
haplamine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine | [no description available] | medium | 1 | 0 | triazoles | |
2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | [no description available] | medium | 1 | 0 | quinolines | |
2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline | [no description available] | medium | 1 | 0 | pyridines; pyrrolidines; quinazolines | |
scp 1 | [no description available] | medium | 1 | 0 | ||
N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-[4-(diethylamino)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
N-(2-furanylmethyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine | [no description available] | medium | 1 | 0 | aromatic amine; thiadiazoles | |
te 5 | [no description available] | medium | 1 | 0 | ||
2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | ureas | |
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | [no description available] | medium | 1 | 0 | benzothiazoles | |
6-methylflavone | [no description available] | medium | 1 | 0 | ||
2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
2-chloro-N-(2-phenylethyl)benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
tioxazafen | [no description available] | medium | 1 | 0 | 1,2,4-oxadiazole; thiophenes | agrochemical; nematicide |
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic amide | |
1-(4-Methoxyphenyl)-2-nitroethylene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
brd32048 | [no description available] | medium | 1 | 0 | methoxybenzenes; substituted aniline | |
2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine | [no description available] | medium | 1 | 0 | imidazoles | |
5-(2-phenyl-4-triazolyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | triazoles | |
N-cyclohexyl-2,3-dihydroindole-1-carboxamide | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide; benzenes; thienopyrimidine | |
2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | |
1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide | [no description available] | medium | 1 | 0 | indolecarboxamide | |
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-(1H-benzimidazol-2-yl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2,5-dimethylphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
N-(4-methoxyphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
2-(9h-xanthen-9-yl)-malonic acid | [no description available] | medium | 1 | 0 | xanthenes | |
1-(1,3-benzothiazol-2-yl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one | [no description available] | medium | 1 | 0 | imidazoles | |
N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-bromo-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | [no description available] | medium | 1 | 0 | indoles | |
N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | triazoles | |
N,N-dimethyl-N'-p-tolylsulfamide | [no description available] | medium | 1 | 0 | sulfamides | marine xenobiotic metabolite |
2-(1-piperidinylmethyl)phenol | [no description available] | medium | 1 | 0 | ||
2,6-bis(benzimidazol-2-yl)pyridine | [no description available] | medium | 1 | 0 | benzimidazoles | |
1-cyclohexyl-3-(2-phenylethyl)urea | [no description available] | medium | 1 | 0 | benzenes | |
1-(3,5-dichlorophenyl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
1-(cyclohexylmethyl)-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
N-phenethyl-2-furamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
paromomycin sulfate | [no description available] | medium | 1 | 0 | ||
N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine | [no description available] | medium | 1 | 0 | aralkylamine | |
N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
vu0099704 | [no description available] | medium | 1 | 0 | ||
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline | [no description available] | medium | 1 | 0 | triazoles | |
2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile | [no description available] | medium | 1 | 0 | ||
(3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
2-fluoro-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone | [no description available] | medium | 1 | 0 | carbonyl compound; thiol | |
GS4012 free base | [no description available] | medium | 1 | 0 | aryl sulfide; monomethoxybenzene; pyridines | VEGF activator |
N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
2-(4-methylanilino)-1-(4-nitrophenyl)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide | [no description available] | medium | 1 | 0 | amino acid amide; glycine derivative | |
2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
4-Piperidinobenzoic acid | [no description available] | medium | 1 | 0 | piperidines | |
1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine | [no description available] | medium | 1 | 0 | benzimidazoles | |
4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide | [no description available] | medium | 1 | 0 | benzodioxine | |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 1 | 0 | ||
8-(3,5-dimethyl-1-pyrazolyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
2'-nitroflavone | [no description available] | medium | 1 | 0 | ||
N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine | [no description available] | medium | 1 | 0 | aminoquinoline | |
1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | [no description available] | medium | 1 | 0 | aromatic compound | |
vrt 532 | [no description available] | medium | 1 | 0 | ||
4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol | [no description available] | medium | 1 | 0 | piperazines | |
1-piperonylpiperidine | [no description available] | medium | 1 | 0 | ||
2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol | [no description available] | medium | 1 | 0 | aromatic amine | |
2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol | [no description available] | medium | 1 | 0 | aromatic amine | |
6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazolopyrimidine | |
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide | [no description available] | medium | 1 | 0 | imidazoles | |
2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine | [no description available] | medium | 1 | 0 | benzoxazole | |
1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea | [no description available] | medium | 1 | 0 | ureas | |
2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid | [no description available] | medium | 1 | 0 | N-acylglycine | |
(4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | aromatic ether; C-nitro compound | |
3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
2-(dimethylsulfamoylamino)-9H-fluorene | [no description available] | medium | 1 | 0 | fluorenes | |
4-chloro-1-ethyl-3-nitro-2-quinolinone | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | [no description available] | medium | 1 | 0 | quinolines | |
2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde | [no description available] | medium | 1 | 0 | arenecarbaldehyde | |
2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide | [no description available] | medium | 1 | 0 | triazoles | |
N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | organofluorine compound | |
4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | [no description available] | medium | 1 | 0 | phthalazines | |
N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | phthalimides | |
6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | pyridines | |
2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
(2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide | [no description available] | medium | 1 | 0 | carbazoles | |
N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide | [no description available] | medium | 1 | 0 | primary carboxamide; pyrazines; secondary carboxamide | |
N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzodioxoles | |
1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea | [no description available] | medium | 1 | 0 | benzodioxine | |
8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | [no description available] | medium | 1 | 0 | aryl sulfide | |
1-[2-(2-chlorophenoxy)ethyl]benzimidazole | [no description available] | medium | 1 | 0 | benzimidazoles | |
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | [no description available] | medium | 1 | 0 | C-nitro compound | |
2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine | [no description available] | medium | 1 | 0 | triazolopyridazine | |
N-(3-acetylphenyl)-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
oncrasin-1 | [no description available] | medium | 1 | 0 | arenecarbaldehyde; indoles; monochlorobenzenes | antineoplastic agent; apoptosis inducer |
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-(4-anilinophenyl)-2-methylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
N-(2-fluorophenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
1-[(Phenylthio)acetyl]piperidine | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
4-(4-morpholinylmethyl)-3-quinolinol | [no description available] | medium | 1 | 0 | quinolines | |
2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione | [no description available] | medium | 1 | 0 | naphthofuran | |
5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | benzamides | |
1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-propylsulfonyl-4-(2-pyridinyl)piperazine | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
2-(2-phenylethylthio)-3-pyridinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide | [no description available] | medium | 1 | 0 | thiazoles | |
1-cyclohexyl-3-(3-ethylphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
n-phenylpiracetam | [no description available] | medium | 1 | 0 | ||
2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide | [no description available] | medium | 1 | 0 | biphenyls | |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide | [no description available] | medium | 1 | 0 | isoquinolines | |
5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
1,4-bis(thiophen-2-ylsulfonyl)piperazine | [no description available] | medium | 1 | 0 | N-sulfonylpiperazine; thiophenes | |
2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | [no description available] | medium | 1 | 0 | ||
2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone | [no description available] | medium | 1 | 0 | quinazolines | |
1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | [no description available] | medium | 1 | 0 | morpholines | |
LSM-4563 | [no description available] | medium | 1 | 0 | aromatic ketone | |
1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | [no description available] | medium | 1 | 0 | sulfonamide | |
2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | medium | 1 | 0 | quinolines | |
N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | tetrazoles | |
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | [no description available] | medium | 1 | 0 | thiazolopyrimidine | |
3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid | |
N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzamides | |
3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
stk295900 | [no description available] | medium | 1 | 0 | ||
1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyridazines; ring assembly | |
1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea | [no description available] | medium | 1 | 0 | ureas | |
N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | methoxybenzenes | |
N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine | [no description available] | medium | 1 | 0 | phthalazines | |
SMER 28 | [no description available] | medium | 1 | 0 | organobromine compound; quinazolines; secondary amino compound | autophagy inducer |
N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | [no description available] | medium | 1 | 0 | morpholines | |
4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | medium | 1 | 0 | aromatic ether | |
4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
N-(3-phenylpropyl)methanesulfonamide | [no description available] | medium | 1 | 0 | benzenes | |
4-acetamido-N-(2-methoxyethyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | [no description available] | medium | 1 | 0 | quinolines | |
5-bromo-N-(2-phenylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | [no description available] | medium | 1 | 0 | aromatic ether | |
3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone | [no description available] | medium | 1 | 0 | aralkylamine | |
4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | piperazinecarboxylic acid | |
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | [no description available] | medium | 1 | 0 | aromatic ether | |
N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | biphenyls | |
5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one | [no description available] | medium | 1 | 0 | ||
2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | nitrophenol | |
2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine | [no description available] | medium | 1 | 0 | quinazolines | |
2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
Methyl(2-furoylamino)acetic acid | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
5-nitro-8-(1-pyrrolidinyl)quinoline | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide | [no description available] | medium | 1 | 0 | amino acid amide | |
2-[(4-methylphenyl)sulfonylamino]pentanoic acid | [no description available] | medium | 1 | 0 | sulfonamide | |
4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine | [no description available] | medium | 1 | 0 | ||
1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide | [no description available] | medium | 1 | 0 | piperidines | |
1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | [no description available] | medium | 1 | 0 | acetamides | |
2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | medium | 1 | 0 | methoxybenzenes | |
3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
(3,5-Dimethyl-1-adamantyl)amine nitrate | [no description available] | medium | 1 | 0 | nitrates | |
1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | [no description available] | medium | 1 | 0 | alkylbenzene | |
N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine | [no description available] | medium | 1 | 0 | aralkylamine | |
N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | medium | 1 | 0 | benzodioxine | |
2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | [no description available] | medium | 1 | 0 | aromatic compound | |
2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | [no description available] | medium | 1 | 0 | pyrrolidines | |
1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | [no description available] | medium | 1 | 0 | methoxybenzenes | |
6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | medium | 1 | 0 | organochlorine compound; pyranopyrazole | |
1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | anilide | |
4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | organosulfur heterocyclic compound | |
[3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone | [no description available] | medium | 1 | 0 | aromatic amide; thiophenes | |
[4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | piperazines | |
N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine | [no description available] | medium | 1 | 0 | piperazines | |
5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline | [no description available] | medium | 1 | 0 | piperazines | |
2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | benzothiazoles | |
N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector |
6,3',4'-Trimethoxyflavanone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
1-[4-(3-ethoxyphenoxy)butyl]imidazole | [no description available] | medium | 1 | 0 | aromatic ether | |
5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
[4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | [no description available] | medium | 1 | 0 | sulfonamide | |
3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
LSM-25805 | [no description available] | medium | 1 | 0 | isoindoles | |
4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | [no description available] | medium | 1 | 0 | 1-benzothiophenes | |
nsc 727447 | [no description available] | medium | 1 | 0 | ||
2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide | [no description available] | medium | 1 | 0 | acetamides | |
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | [no description available] | medium | 1 | 0 | C-nitro compound; thiazoles | |
7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | medium | 1 | 0 | methoxybenzenes | |
N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | nitrophenol | |
2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | [no description available] | medium | 1 | 0 | quinolines | |
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | [no description available] | medium | 1 | 0 | C-nitro compound | |
3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one | [no description available] | medium | 1 | 0 | ||
N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; thiazoles | |
ex 527 | [no description available] | medium | 1 | 0 | carbazoles; monocarboxylic acid amide; organochlorine compound | |
3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | [no description available] | medium | 1 | 0 | indoles | |
4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one | [no description available] | medium | 1 | 0 | phenylpyridine | |
3-methylharman | [no description available] | medium | 1 | 0 | ||
1-methyl-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | ||
sildenafil | [no description available] | medium | 1 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
2-methyl-4(3h)-quinazolinone | [no description available] | medium | 1 | 0 | ||
n(4)-desoxychlordiazepoxide | [no description available] | medium | 1 | 0 | ||
2-amino-3-hydroxyphenazine | [no description available] | medium | 1 | 0 | ||
2-styrylquinazolin-4(3h)-one | [no description available] | medium | 1 | 0 | ||
2-amino-5-iodo-6-phenyl-4-pyrimidinone | [no description available] | medium | 1 | 0 | ||
quininib | [no description available] | medium | 1 | 0 | phenols; styrylquinoline | angiogenesis inhibitor |
bropirimine | [no description available] | medium | 1 | 0 | pyrimidines | |
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
acetazolamide | [no description available] | low | 0 | 0 | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol | [no description available] | low | 0 | 0 | sulfonamide | |
amosulalol | [no description available] | low | 0 | 0 | sulfonamide | |
ampiroxicam | [no description available] | low | 0 | 0 | acetal; aminopyridine; benzothiazine; etabonate ester; monocarboxylic acid amide; sulfonamide | analgesic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; prodrug |
amsacrine | [no description available] | low | 0 | 0 | acridines; aromatic ether; sulfonamide | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
azosemide | [no description available] | low | 0 | 0 | monochlorobenzenes; sulfonamide; tetrazoles; thiophenes | loop diuretic |
bendroflumethiazide | [no description available] | low | 0 | 0 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
benzothiazide | [no description available] | low | 0 | 0 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
benzylhydrochlorothiazide | [no description available] | low | 0 | 0 | benzenes; benzothiadiazine; organochlorine compound; secondary amino compound; sulfonamide | |
bumetanide | [no description available] | low | 0 | 0 | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
celecoxib | [no description available] | low | 0 | 0 | organofluorine compound; pyrazoles; sulfonamide; toluenes | cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
chlorthalidone | [no description available] | low | 0 | 0 | isoindoles; monochlorobenzenes; sulfonamide | |
4-chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
dichlorphenamide | [no description available] | low | 0 | 0 | dichlorobenzene; sulfonamide | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug |
e 4031 | [no description available] | low | 0 | 0 | sulfonamide | |
ethoxzolamide | [no description available] | low | 0 | 0 | aromatic ether; benzothiazoles; sulfonamide | antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
famotidine | [no description available] | low | 0 | 0 | 1,3-thiazoles; guanidines; sulfonamide | anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
furosemide | [no description available] | low | 0 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
glimepiride | [no description available] | low | 0 | 0 | sulfonamide | |
n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide | [no description available] | low | 0 | 0 | isoquinolines; sulfonamide | |
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | [no description available] | low | 0 | 0 | bromobenzenes; isoquinolines; olefinic compound; secondary amino compound; sulfonamide | EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor |
hydrochlorothiazide | [no description available] | low | 0 | 0 | benzothiadiazine; organochlorine compound; sulfonamide | antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
hydroxymethyltolbutamide | [no description available] | low | 0 | 0 | benzyl alcohols; sulfonamide; ureas | metabolite |
indapamide | [no description available] | low | 0 | 0 | indoles; organochlorine compound; sulfonamide | antihypertensive agent; diuretic |
methazolamide | [no description available] | low | 0 | 0 | sulfonamide; thiadiazoles | |
metolazone | [no description available] | low | 0 | 0 | organochlorine compound; quinazolines; sulfonamide | antihypertensive agent; diuretic; ion transport inhibitor |
monodansylcadaverine | [no description available] | low | 0 | 0 | aminonaphthalene; primary amino compound; sulfonamide; tertiary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor; fluorochrome; protective agent |
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; organochlorine compound; primary amino compound; sulfonamide | |
naratriptan | [no description available] | low | 0 | 0 | heteroarylpiperidine; sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
nimesulide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor |
5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide | [no description available] | low | 0 | 0 | sulfonamide | |
phthalylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; dicarboxylic acid monoamide; sulfonamide antibiotic; sulfonamide | |
probenecid | [no description available] | low | 0 | 0 | benzoic acids; sulfonamide | uricosuric drug |
sulfadiazine | [no description available] | low | 0 | 0 | pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
sotalol | [no description available] | low | 0 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
SU6656 | [no description available] | low | 0 | 0 | oxindoles; sulfonamide | antineoplastic agent; Aurora kinase inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
sulfabenzamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide antibiotic; sulfonamide | antibacterial drug; antimicrobial drug |
sulfacytine | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
sulfamerazine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen |
sulfameter | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent; leprostatic drug; renal agent |
sulfamethizole | [no description available] | low | 0 | 0 | sulfonamide antibiotic; sulfonamide; thiadiazoles | antiinfective agent; antimicrobial agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
sulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic |
sulfamethoxypyridazine | [no description available] | low | 0 | 0 | pyridazines; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
sulfamonomethoxine | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
sulfanilamide | [no description available] | low | 0 | 0 | substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
sulfanitran | [no description available] | low | 0 | 0 | sulfonamide | |
sulfaphenazole | [no description available] | low | 0 | 0 | primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor |
sulfapyridine | [no description available] | low | 0 | 0 | pyridines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic |
sulfaquinoxaline | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
sulfisomidine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent |
sulfisoxazole | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide antibiotic; sulfonamide | antibacterial drug; drug allergen |
sulfoxone | [no description available] | low | 0 | 0 | sulfonamide | |
sulpiride | [no description available] | low | 0 | 0 | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
sumatriptan | [no description available] | low | 0 | 0 | sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
delavirdine | [no description available] | low | 0 | 0 | aminopyridine; indolecarboxamide; N-acylpiperazine; sulfonamide | antiviral drug; HIV-1 reverse transcriptase inhibitor |
zonisamide | [no description available] | low | 0 | 0 | 1,2-benzoxazoles; sulfonamide | anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker |
4-toluenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
n-methyl-n-nitrosotoluene-p-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
sulfachlorpyridazine | [no description available] | low | 0 | 0 | organochlorine compound; pyridazines; sulfonamide | antibacterial drug; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
acetyl sulfisoxazole | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
sulfaethidole | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
sulfalene | [no description available] | low | 0 | 0 | pyrazines; sulfonamide antibiotic; sulfonamide | |
thioproperazine | [no description available] | low | 0 | 0 | N-alkylpiperazine; N-methylpiperazine; phenothiazines; sulfonamide | phenothiazine antipsychotic drug |
carbutamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
glymidine | [no description available] | low | 0 | 0 | diether; pyrimidines; sulfonamide | hypoglycemic agent |
thiazosulfone | [no description available] | low | 0 | 0 | sulfonamide | |
glybuthiazol | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
sulfanilylurea | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
metahexamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
clopamide | [no description available] | low | 0 | 0 | sulfonamide | |
tolcyclamide | [no description available] | low | 0 | 0 | sulfonamide | |
sulfamoxole | [no description available] | low | 0 | 0 | oxazole; sulfonamide antibiotic; sulfonamide | antimicrobial agent; drug allergen |
sulfaethoxypyridazine | [no description available] | low | 0 | 0 | sulfonamide | antibacterial agent |
4-((diethylamino)sulfonyl)benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
dinsed | [no description available] | low | 0 | 0 | sulfonamide | |
amidephrine | [no description available] | low | 0 | 0 | sulfonamide | |
sulfadoxine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide | antibacterial drug; antimalarial |
hydroxyhexamide | [no description available] | low | 0 | 0 | sulfonamide | |
asulam | [no description available] | low | 0 | 0 | carbamate ester; primary amino compound; substituted aniline; sulfonamide | agrochemical; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; herbicide; xenobiotic |
oryzalin | [no description available] | low | 0 | 0 | aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound | agrochemical; antimitotic; herbicide |
glisoxepide | [no description available] | low | 0 | 0 | sulfonamide | |
perfluidone | [no description available] | low | 0 | 0 | sulfonamide | |
mefluidide | [no description available] | low | 0 | 0 | sulfonamide | |
2-aminosulfonyl-benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester; methyl ester; sulfonamide | marine xenobiotic metabolite |
clorsulon | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
agreal | [no description available] | low | 0 | 0 | sulfonamide | |
n-acetylsulfapyridine | [no description available] | low | 0 | 0 | sulfonamide | |
tirofiban | [no description available] | low | 0 | 0 | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
amprenavir | [no description available] | low | 0 | 0 | carbamate ester; sulfonamide; tetrahydrofuryl ester | antiviral drug; HIV protease inhibitor |
n(4)-acetylsulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | drug metabolite; marine xenobiotic metabolite |
glisentide | [no description available] | low | 0 | 0 | sulfonamide | |
ebrotidine | [no description available] | low | 0 | 0 | sulfonamide | |
4-chlorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-amino-6-chloro-1,3-benzenedisulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N(4)-acetylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; acetamides; sulfonamide | marine xenobiotic metabolite |
2-benzothiazolesulfonamide | [no description available] | low | 0 | 0 | benzothiazoles; sulfonamide | |
brinzolamide | [no description available] | low | 0 | 0 | sulfonamide; thienothiazine | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
piloty's acid | [no description available] | low | 0 | 0 | sulfonamide | |
perfluorooctanesulfonamide | [no description available] | low | 0 | 0 | perfluorinated compound; sulfonamide | persistent organic pollutant |
uk 68798 | [no description available] | low | 0 | 0 | aromatic ether; sulfonamide; tertiary amino compound | anti-arrhythmia drug; potassium channel blocker |
glyclopyramide | [no description available] | low | 0 | 0 | sulfonamide | |
fluoresone | [no description available] | low | 0 | 0 | sulfonamide | |
2-aminobenzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
4-chloro-5-sulfamoylanthranilic acid | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
sulfluramid | [no description available] | low | 0 | 0 | sulfonamide | acaricide; environmental contaminant; insecticide; xenobiotic |
n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide | [no description available] | low | 0 | 0 | dichlorobenzene; organofluorine compound; sulfonamide; triazoles | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
cloransulam-methyl | [no description available] | low | 0 | 0 | methyl ester; monochlorobenzenes; organofluorine compound; sulfonamide; triazolopyrimidines | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
sdds | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
4-chlorobenzenesulfonylurea | [no description available] | low | 0 | 0 | sulfonamide | |
n-(2,6-difluorophenyl)-5-methyl(1,2,4)-triazol(1,5-a)pyrimidine-2-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
flazasulfuron | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
bosentan anhydrous | [no description available] | low | 0 | 0 | primary alcohol; pyrimidines; sulfonamide | antihypertensive agent; endothelin receptor antagonist |
sulfamethoxazole hydroxylamine | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | allergen; metabolite |
gr 113808 | [no description available] | low | 0 | 0 | indolyl carboxylate ester; piperidines; sulfonamide | serotonergic antagonist |
valdecoxib | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | antipyretic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
ym 12617 | [no description available] | low | 0 | 0 | aromatic ether; secondary amino compound; sulfonamide | |
dansyllysine | [no description available] | low | 0 | 0 | L-lysine derivative; non-proteinogenic L-alpha-amino acid; sulfonamide | epitope |
almotriptan | [no description available] | low | 0 | 0 | indoles; sulfonamide; tertiary amine | non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
4-nitrososulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; nitroso compound; sulfonamide | allergen; metabolite |
cki 7 | [no description available] | low | 0 | 0 | isoquinolines; organochlorine compound; primary amino compound; sulfonamide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
fosamprenavir | [no description available] | low | 0 | 0 | sulfonamide | prodrug |
metipamide | [no description available] | low | 0 | 0 | sulfonamide | |
jte 522 | [no description available] | low | 0 | 0 | 1,3-oxazoles; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor |
carboxytolbutamide | [no description available] | low | 0 | 0 | sulfonamide | |
tevenel | [no description available] | low | 0 | 0 | sulfonamide | |
sulfachlorpyrazine | [no description available] | low | 0 | 0 | sulfonamide | |
n(4)-acetylsulfadimethoxine | [no description available] | low | 0 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
dronedarone | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound | anti-arrhythmia drug; environmental contaminant; xenobiotic |
darunavir | [no description available] | low | 0 | 0 | carbamate ester; furofuran; sulfonamide | antiviral drug; HIV protease inhibitor |
cimicoxib | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
dabuzalgron | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; monochlorobenzenes; sulfonamide | alpha-adrenergic agonist |
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide | [no description available] | low | 0 | 0 | chloroindole; organochlorine compound; sulfonamide | antineoplastic agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
3,4-Dichlorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-cyclooctyl-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
tolpyrramide | [no description available] | low | 0 | 0 | sulfonamide | |
acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
tosylphenylalanyl chloromethyl ketone | [no description available] | low | 0 | 0 | alpha-chloroketone; sulfonamide | alkylating agent; serine proteinase inhibitor |
rosuvastatin | [no description available] | low | 0 | 0 | dihydroxy monocarboxylic acid; monofluorobenzenes; pyrimidines; statin (synthetic); sulfonamide | anti-inflammatory agent; antilipemic drug; cardioprotective agent; CETP inhibitor; environmental contaminant; xenobiotic |
bms 214662 | [no description available] | low | 0 | 0 | benzenes; benzodiazepine; imidazoles; nitrile; sulfonamide; thiophenes | antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor |
prinomastat | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid; pyridines; sulfonamide; thiomorpholines | antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; matrix metalloproteinase inhibitor |
glucosulfone | [no description available] | low | 0 | 0 | sulfonamide | |
1-[1-(benzenesulfonyl)-3-pyrrolyl]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-bromo-2,5-dimethoxyphenyl)sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-chloro-3-methoxyphenyl)sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
6-[(4-methylphenyl)sulfonyl]-6-azabicyclo[3.2.1]octane | [no description available] | low | 0 | 0 | sulfonamide | |
N-cyclopentyl-4-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]sulfonyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(3-ethoxyphenyl)-1-(4-methoxyphenyl)sulfonyl-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[2-[1-(4-methoxyphenyl)sulfonyl-2-benzimidazolyl]ethyl]morpholine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,5-dimethoxyphenyl)sulfonyl-N-(phenylmethyl)-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[2-chloro-5-(trifluoromethyl)phenyl]sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
4-[4-[(5,6-dimethyl-1-benzimidazolyl)sulfonyl]phenyl]sulfonylmorpholine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-methoxyphenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
4-methyl-N-(pyridin-4-ylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-(benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-furanylmethyl)-2-[(4-methoxyphenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N,N-dimethyl-4-[[4-(5-methyl-1-benzotriazolyl)-1-piperidinyl]sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide | [no description available] | low | 0 | 0 | acetamides; piperidines; pyridines; sulfonamide | |
3,4,5-trimethoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-phenylmethoxyphenyl)methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-fluoro-3-methylphenyl)sulfonylamino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-chlorophenyl)-3-(4-sulfamoylphenyl)urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-(3-chloro-4-hydroxy-2,5-dimethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(1-cyclohexenyl)ethyl]-2,5-dimethoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-methyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-chloro-N-(4-hydrazinyl-6-methyl-2-pyrimidinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-amino-N-(4-ethoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
1-(2-nitrophenyl)sulfonylpiperidine | [no description available] | low | 0 | 0 | sulfonamide | |
N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[4-(1-pyrrolidinylsulfonyl)phenyl]hydrazinylidene]propanedinitrile | [no description available] | low | 0 | 0 | sulfonamide | |
N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3-chlorophenyl)sulfonylpyrrolidine | [no description available] | low | 0 | 0 | sulfonamide | |
1-cyclopropyl-3-(4-sulfamoylphenyl)thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[methyl(methylsulfonyl)amino]-N-(2-phenylethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(2,6-dichloroanilino)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
4-(4-chloroanilino)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
1-ethyl-3-(4-methylphenyl)sulfonylthiourea | [no description available] | low | 0 | 0 | sulfonamide | |
6-chloro-N-(2-hydroxyphenyl)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(2,5-dimethoxyphenyl)sulfonyl-methylamino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(1-cyclohexenyl)ethyl]-4-[methyl(methylsulfonyl)amino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,5-dimethoxyphenyl)sulfonyl-4-ethylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,3,5,6-tetramethyl-N-(2-methyl-1,3-benzothiazol-5-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-chloro-2-methyl-5-(2-pyridinylsulfamoyl)phenoxy]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(3-chlorophenyl)-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(5-bromo-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[(2,6-dimethoxy-4-pyrimidinyl)sulfamoyl]phenyl]butanamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(3-pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole | [no description available] | low | 0 | 0 | sulfonamide | |
5-bromo-6-chloro-N-(4-methyl-2-pyridinyl)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
4-(4-fluorophenyl)sulfonyl-2-(2-furanyl)-N-phenyl-5-oxazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[4-(4-methylphenyl)sulfonyl-1-piperazinyl]methyl]-4-propan-2-ylphenol | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2-chlorophenyl)methyl]-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-ethoxyphenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(1-piperidinylsulfonyl)phenyl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1,3-benzothiazol-2-yl)-2-[methyl-(4-methylphenyl)sulfonylamino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-cyclohexyl-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-ethoxy-2,3,5-trimethyl-N-(3-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[N-(benzenesulfonyl)-4-ethoxyanilino]-N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
5-bromo-2-methoxy-N-(3-methyl-2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
pyrabactin | [no description available] | low | 0 | 0 | naphthalenes; organobromine compound; pyridines; sulfonamide | abscisic acid receptor agonist; hormone; plant growth regulator |
1,4-bis[(4-methoxy-2-methylphenyl)sulfonyl]-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-furanylmethyl)-4-(1-pyrrolidinylsulfonyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(benzenesulfonyl)-N-methyl-N-phenyl-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[[1-(benzenesulfonyl)-4-piperidinyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(1,3-benzodioxol-5-yl)-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
1-(1,3-benzodioxol-5-yl)-3-[4-[(phenylmethyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
1,3-diethyl-6-methyl-N-(2-methylphenyl)-2-oxo-5-benzimidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1,3-benzodioxol-5-ylmethyl)-4-methyl-3-(1-piperidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-methylsulfonyl-N-(6,7,8,9-tetrahydrodibenzofuran-2-yl)-2,3-dihydroindole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-hydroxy-3,5-dimethylphenyl)-2,5-dimethyl-3-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
5-[(5-tert-butyl-2,3-dimethylphenyl)sulfonylamino]-2-hydroxybenzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-chloro-5-(cyclopentylsulfamoyl)-2-methylphenoxy]-N-cyclohexylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[1-(4-tert-butylphenyl)sulfonyl-4-piperidinyl]-6-chloro-1H-benzimidazole | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-[4-(1-pyrrolidinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
7-methyl-2-[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]-3-quinolinecarbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
6-amino-5-(benzenesulfonyl)-2-methoxy-3-pyridinecarbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
6-amino-5-(4-chlorophenyl)sulfonyl-2-oxo-1H-pyridine-3-carbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
2-[benzenesulfonyl(2-pyridinyl)amino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-chlorophenyl)sulfonyl-(2-pyridinyl)amino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
2,5-dichloro-N-(1,5,6-trimethyl-4-benzimidazolyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
5-[1-(benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole | [no description available] | low | 0 | 0 | sulfonamide | |
5-[1-(4-fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole | [no description available] | low | 0 | 0 | sulfonamide | |
N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(benzenesulfonylmethyl)-5-(4-chlorophenyl)cyclohexane-1,3-dione | [no description available] | low | 0 | 0 | sulfonamide | |
1-(benzenesulfonyl)-3-pyrazolidinone | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-4-pyrazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-methoxyphenyl)-2-(3-methylphenoxy)-N-(4-methylphenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[[4-(diethylsulfamoyl)phenyl]-oxomethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
tosylarginine methyl ester | [no description available] | low | 0 | 0 | guanidines; L-arginine ester; methyl ester; sulfonamide | |
n-(4-(n-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide | [no description available] | low | 0 | 0 | pyrazines; sulfonamide; thiophenes | necroptosis inhibitor; neuroprotective agent |
N-[(benzenesulfonylhydrazo)-sulfanylidenemethyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
xl147 | [no description available] | low | 0 | 0 | aromatic amine; benzothiadiazole; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
7-chloro-2-methyl-4-(4-methylphenyl)sulfonylthiazolo[5,4-b]indole | [no description available] | low | 0 | 0 | sulfonamide | |
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(4-bromophenyl)sulfonyl-2-(2-furanyl)-5-(methylthio)oxazole | [no description available] | low | 0 | 0 | sulfonamide | |
4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
3-[4-(4-morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
2,5-difluoro-N-[2-(4-morpholinylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-methyl-1,3-benzothiazol-6-yl)-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-[(4-acetyl-1-piperazinyl)sulfonyl]-N-(1H-benzimidazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-[(3-hydroxy-5-benzotriazolyl)sulfonylamino]benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-[[[5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1,2,3-benzotriazin-4-one | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1H-benzimidazol-2-yl)-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,6-dichloro-N-[2-(methylthio)-1,3-benzothiazol-6-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-fluoro-3-methoxy-N-(2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-[methyl(phenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[bis(2-methoxyethyl)sulfamoyl]-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[butyl(methyl)sulfamoyl]-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[ethyl-(phenylmethyl)sulfamoyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[ethyl-(phenylmethyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-methyl-2-thiazolyl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-nitrobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-ethoxy-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-furanylmethyl)-2-[4-(propylsulfamoyl)phenoxy]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-methyl-N-[2-(phenylmethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-chloro-5-(cyclohexylsulfamoyl)-2-methylphenoxy]-N-(1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3-chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-ethoxyphenyl)-4-[[4-(methylthio)phenyl]sulfonylamino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(methanesulfonamido)-N-[2-(phenylmethylthio)ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[benzenesulfonyl-(phenylmethyl)amino]-N-ethylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[benzenesulfonyl(methyl)amino]-N-[2-[(4-chlorophenyl)methylthio]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(3,4-dimethyl-2-sulfanylidene-5-thiazolyl)carbamic acid 2-[(2,5-dimethylphenyl)sulfonylamino]ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
2-[cyclohexyl-(4-methylphenyl)sulfonylamino]-N-(3-methoxypropyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1H-benzimidazol-2-yl)-4-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3-chlorophenyl)-3-[2-(thiophen-2-ylsulfonylamino)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1H-benzimidazol-2-ylmethyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-cyanophenyl)methylthio]-N-(2-methoxyphenyl)-1,3-benzoxazole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-(1-azepanylsulfonyl)-4-chloro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
sr 3335 | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1H-benzimidazol-2-ylmethyl)-4-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-chlorophenyl)methylthio]-5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | sulfonamide | |
4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
3-(2-chlorophenyl)sulfonylpropanoic acid [2-[(3,5-dichloro-6-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-[benzenesulfonyl(methyl)amino]phenoxy]-N-(1,3-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(6-methoxy-1,3-benzothiazol-2-yl)-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-cyclopentyl-3,4-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
6-amino-1-(2-methoxyethyl)-N-(4-methylphenyl)sulfonyl-2,4-dioxo-5-pyrimidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-(benzenesulfonyl)propanoic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
[4-(4-bromo-2-chlorophenyl)sulfonyl-1-piperazinyl]-(2-sulfanylidene-1H-pyridin-3-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
[1-(4-fluorophenyl)sulfonyl-4-piperidinyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(3-chloro-2,4,6-trifluorophenyl)sulfonyl-1-piperazinyl]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
2-(4-methoxyphenyl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N1-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(benzenesulfonylmethyl)-5-(4-methoxyphenyl)cyclohexane-1,3-dione | [no description available] | low | 0 | 0 | sulfonamide | |
2-[bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
N1-{3-[2-(2-pyridyl)ethyl]phenyl}-4-chlorobenzene-1-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate | [no description available] | low | 0 | 0 | ethyl ester; monochlorobenzenes; organofluorine compound; pyrazoles; sulfonamide | |
2,3-dichloro-N'-[4-(trifluoromethyl)-2-pyrimidinyl]benzenesulfonohydrazide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3,5-dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-tert-butyl-3-[(4-methylphenyl)sulfonylamino]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
3-methyl-4,7-bis(methylsulfonyl)-3a,5,6,7a-tetrahydro-1H-imidazo[4,5-b]pyrazin-2-one | [no description available] | low | 0 | 0 | imidazopyrazine; sulfonamide; ureas | |
N-(3-acetyl-2-methyl-5-benzofuranyl)-N-(4-chloro-3-nitrophenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(4-chlorophenyl)thio]-N-[4-[(2,4-dimethylphenyl)sulfamoyl]phenyl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-chloro-N-[2-(4-morpholinyl)cyclohexyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[3-(2-furanyl)-3-phenylpropyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-(butylsulfamoyl)phenyl]-2-phenyl-2-(phenylthio)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiazolyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[oxo-[1-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinyl]methyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
N,4-dimethyl-N-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[1-(4-chlorophenyl)sulfonyl-2-pyrrolidinyl]-4-methyl-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[1-(2-methylpropyl)-2-benzimidazolyl]thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
6-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-N-ethyl-N-phenyl-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
4-chloro-N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,3-dihydro-1,4-benzodioxin-3-yl-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(benzenesulfonyl)-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
sulfatolamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
e 7010 | [no description available] | low | 0 | 0 | sulfonamide | |
deracoxib | [no description available] | low | 0 | 0 | organofluorine compound; pyrazoles; sulfonamide | cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
diclosulam | [no description available] | low | 0 | 0 | sulfonamide | |
benzene-1-3-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-nitro-N-(pyridin-4-ylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[2-[(4-acetamidophenyl)sulfonylamino]-4-thiazolyl]acetic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
1-[3-(benzenesulfonyl)-2-(1-piperidinyl)propyl]piperidine | [no description available] | low | 0 | 0 | sulfonamide | |
6-(2-furanyl)-4-[4-(methanesulfonamido)phenyl]-2-oxo-1-cyclohex-3-enecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2-furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
N1-butan-2-yl-N4-[2-(3,4-dimethoxyphenyl)ethyl]-N4-(thiophen-2-ylmethyl)benzene-1,4-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-chlorophenyl)sulfonyl-N'-[oxo-[4-(1-piperidinylsulfonyl)phenyl]methyl]-4-piperidinecarbohydrazide | [no description available] | low | 0 | 0 | sulfonamide | |
N,N-dimethyl-4-[[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]sulfonyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-methylphenyl)sulfonyl-3-methylsulfonylimidazolidine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-chlorophenyl)sulfonyl-N-(2-thiazolyl)-1-cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methylanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N,N-diethyl-4-[[5-oxo-6-(phenylmethyl)-7H-pyrrolo[3,4-b]pyridin-7-yl]amino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1,3-benzodioxol-5-yl)-5-bromo-1-[cyclopropyl(oxo)methyl]-N-ethyl-2,3-dihydroindole-7-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-methyl-N-[2,4,6-trioxo-1-phenyl-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
6-ethyl-2-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(5-chloro-1,3-benzothiazol-2-yl)thio]-N-[3-(4-morpholinylsulfonyl)phenyl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxy-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-ethoxy-3-pyridinecarboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[2-(2-ethyl-1-oxobutyl)-3-phenyl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[3-[(2-chlorophenyl)sulfamoyl]-4-methoxyphenyl]-4-oxo-4-thiophen-2-ylbutanamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
fh535 | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[[5-(dimethylsulfamoyl)-2-methylanilino]-sulfanylidenemethyl]hydrazo]-2-oxoacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-butylphenyl)-3-[4-chloro-3-(dimethylsulfamoyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
6-methyl-2-[[oxo-[4-(1-pyrrolidinylsulfonyl)phenyl]methyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(1,3-benzothiazol-2-ylthio)-N-[2-hydroxy-5-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-butyl-4,6-dimethyl-3-(2-methylphenyl)sulfonyl-2-pyridinone | [no description available] | low | 0 | 0 | sulfonamide | |
4-(4-methylphenyl)sulfonyl-3-phenyl-2,3-dihydro-1,4-benzoxazine | [no description available] | low | 0 | 0 | sulfonamide | |
N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide | [no description available] | low | 0 | 0 | 1,4-naphthoquinones; piperazines; sulfonamide | |
N-(2,2,4-trimethyl-3H-benzofuran-7-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-furanyl-[4-(4-propan-2-ylphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | sulfonamide | |
5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-2-[(2,5-dimethylphenyl)thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-[3-(1-imidazolyl)propyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[3-(3-oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(1,2-dimethyl-5-indolyl)methyl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N,6-dimethyl-2-[[[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-cyclopropyl-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[1-(1H-benzimidazol-2-yl)ethyl]-3-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,3-dihydro-1,4-benzodioxin-3-carboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(1,3-benzothiazol-2-ylthio)-N-[2-chloro-5-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[3-(dimethylsulfamoyl)phenyl]-3-(2-furanylmethyl)thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
5-nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[3-[2-(4-fluorophenyl)sulfonyl-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]ethanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-[(2-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(3,5-dimethyl-1-piperidinyl)-sulfanylidenemethyl]-2-methyl-5-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[bis(2-methoxyethyl)sulfamoyl]-N-[5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(benzenesulfonamido)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl ester | [no description available] | low | 0 | 0 | isopropyl ester; sulfonamide | |
2-(3,4-dichlorophenyl)-N-[3-(dimethylsulfamoyl)-4-methylphenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide | [no description available] | low | 0 | 0 | sulfonamide | anticoronaviral agent |
N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(4-methoxyphenyl)-3-[3-(1-piperidinylsulfonyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
1-[2-(trifluoromethyl)phenyl]sulfonyl-4-piperidinecarboxylic acid [2-[(4-fluorophenyl)methylamino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid [2-[4-methyl-3-(1-piperidinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
3-[4-(4-butan-2-ylphenyl)sulfonyl-1-piperazinyl]butanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[4-(2-methoxyphenyl)sulfonyl-1-piperazinyl]sulfonyl]benzonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)-N-prop-2-enylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(7-methyloctyl)-3-[4-(4-morpholinylsulfonyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
5-[(5-bromo-2-ethoxyphenyl)sulfonylamino]-2-chloro-N,N-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-(3-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(dimethylsulfamoyl)-N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-methyl-2-[[[4-[methyl(phenyl)sulfamoyl]phenyl]-oxomethyl]amino]-6-propyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea | [no description available] | low | 0 | 0 | sulfonamide | |
dorzolamide | [no description available] | low | 0 | 0 | sulfonamide; thiophenes | antiglaucoma drug; antihypertensive agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
3-(4-methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid | [no description available] | low | 0 | 0 | sulfonamide | |
N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
5-[(4-methoxyphenyl)sulfonylmethyl]-N-(3-methoxypropyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-cyclohexyl-N-ethyl-1,3-dimethyl-2,4-dioxo-5-pyrimidinesulfonamide | [no description available] | low | 0 | 0 | pyrimidone; sulfonamide | |
1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2,5-dimethoxy-N-[[2-(4-methoxyphenyl)-4-thiazolyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
kn 93 | [no description available] | low | 0 | 0 | monochlorobenzenes; monomethoxybenzene; primary alcohol; sulfonamide; tertiary amino compound | EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor; geroprotector |
ro 4-6790 | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
jnj-7706621 | [no description available] | low | 0 | 0 | sulfonamide | |
sultan | [no description available] | low | 0 | 0 | sulfonamide | |
1-[2-furanyl(oxo)methyl]-N-[4-[(3-methyl-1-piperidinyl)sulfonyl]phenyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
sb 269970 | [no description available] | low | 0 | 0 | sulfonamide | |
belinostat | [no description available] | low | 0 | 0 | hydroxamic acid; olefinic compound; sulfonamide | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
2-bromo-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine | [no description available] | low | 0 | 0 | sulfonamide | |
((3z)-n-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1h-pyrrol-2-yl)methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide) | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
5-chloro-N-[4-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | organofluorine compound; pyrazoles; sulfonamide | cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
bm 567 | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
mre 269 | [no description available] | low | 0 | 0 | aromatic amine; ether; monocarboxylic acid; pyrazines; sulfonamide; tertiary amino compound | drug metabolite; orphan drug; platelet aggregation inhibitor; prostacyclin receptor agonist; vasodilator agent |
pazopanib | [no description available] | low | 0 | 0 | aminopyrimidine; indazoles; sulfonamide | angiogenesis modulating agent; antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist |
azd2858 | [no description available] | low | 0 | 0 | aromatic amine; N-methylpiperazine; pyrazines; pyridines; secondary carboxamide; sulfonamide | antineoplastic agent; bone density conservation agent; EC 2.7.11.26 (tau-protein kinase) inhibitor; Wnt signalling activator |
4-(2-((1r)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
apratastat | [no description available] | low | 0 | 0 | sulfonamide | |
N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
florasulam | [no description available] | low | 0 | 0 | sulfonamide | |
(1S,2R)-2-[[4-[(2,4-dimethylphenyl)sulfamoyl]anilino]-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | low | 0 | 0 | sulfonamide | |
3-[1-(4-bromophenyl)sulfonyl-3,6-dihydro-2H-pyridin-4-yl]-1,2-dimethylindole | [no description available] | low | 0 | 0 | sulfonamide | |
4-[3-(3-fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
2-[[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[3-(4-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
calcium crimson | [no description available] | low | 0 | 0 | ammonium betaine; sulfonamide | fluorochrome |
4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N'-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide | [no description available] | low | 0 | 0 | sulfonamide | |
tg101209 | [no description available] | low | 0 | 0 | N-alkylpiperazine; N-arylpiperazine; pyrimidines; secondary amino compound; sulfonamide | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
fedratinib | [no description available] | low | 0 | 0 | sulfonamide | |
WAY-316606 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; piperidines; secondary amino compound; sulfonamide; sulfone | secreted frizzled-related protein 1 inhibitor |
azd5438 | [no description available] | low | 0 | 0 | sulfonamide | |
gdc 0941 | [no description available] | low | 0 | 0 | indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine | EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
gsk 1016790a | [no description available] | low | 0 | 0 | 1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide | TRPV4 agonist |
plx 4720 | [no description available] | low | 0 | 0 | aromatic ketone; difluorobenzene; organochlorine compound; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor |
gsk 2126458 | [no description available] | low | 0 | 0 | aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide | anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent |
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-fluorophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
(2R)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
[4-(2,6-difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
(2R)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
(2S)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
(2S)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-pyridinylsulfonyl)piperazine | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
N-[1-(2,6-difluorophenyl)sulfonyl-4-piperidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[3-(trifluoromethyl)phenyl]sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[3-[(2,6-difluorophenyl)sulfonylamino]propyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[5-[(2,6-difluorophenyl)sulfonylamino]pentyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[6-[(2,6-difluorophenyl)sulfonylamino]hexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-[(2,6-difluorophenyl)sulfonylamino]ethyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[(2,6-difluorophenyl)sulfonylamino]butyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
4-[4-(4-methylphenyl)sulfonyl-1-piperazinyl]-2-thiophen-2-ylquinazoline | [no description available] | low | 0 | 0 | sulfonamide | |
plx4032 | [no description available] | low | 0 | 0 | aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor |
N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3-chlorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
1-(3-bromophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
(1S,4S)-2-(2,6-difluorophenyl)sulfonyl-5-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2,5-diazabicyclo[2.2.1]heptane | [no description available] | low | 0 | 0 | sulfonamide | |
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2,4,6-trifluorophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1-cyano-3-pyrrolidinyl)-3-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(1-cyano-4-piperidinyl)-4-(trifluoromethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[3-(3-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide | [no description available] | low | 0 | 0 | sulfonamide | |
3-cyclohexyl-1-[[(2S,3S)-8-[(4-fluorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | sulfonamide | |
3-cyclohexyl-1-[[(2R,3R)-10-[(4-fluorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | sulfonamide | |
4-chloro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
baricitinib | [no description available] | low | 0 | 0 | azetidines; nitrile; pyrazoles; pyrrolopyrimidine; sulfonamide | anti-inflammatory agent; antirheumatic drug; antiviral agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; immunosuppressive agent |
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
sr1001 | [no description available] | low | 0 | 0 | sulfonamide | |
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
dabrafenib | [no description available] | low | 0 | 0 | 1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide | anticoronaviral agent; antineoplastic agent; B-Raf inhibitor |
3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
4-[[(4-ethylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
EG00229 | [no description available] | low | 0 | 0 | benzothiadiazole; dicarboxylic acid monoamide; L-arginine derivative; secondary carboxamide; sulfonamide; thiophenes | angiogenesis inhibitor; antineoplastic agent; neuropilin receptor antagonist |
gsk0660 | [no description available] | low | 0 | 0 | sulfonamide | |
xl765 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)-oxomethyl]-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
tipranavir | [no description available] | low | 0 | 0 | sulfonamide | antiviral drug; HIV protease inhibitor |
abt-333 | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; pyrimidone; sulfonamide | antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor |
pik 75 | [no description available] | low | 0 | 0 | sulfonamide | |
vx-970 | [no description available] | low | 0 | 0 | sulfonamide | |
pf-543 | [no description available] | low | 0 | 0 | sulfonamide | |
ML355 | [no description available] | low | 0 | 0 | benzothiazoles; monomethoxybenzene; phenols; secondary amino compound; substituted aniline; sulfonamide | EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; platelet aggregation inhibitor |
sr9243 | [no description available] | low | 0 | 0 | bromobenzenes; sulfonamide; sulfone | antineoplastic agent; apoptosis inducer; liver X receptor inverse agonist |
da 8159 | [no description available] | low | 0 | 0 | sulfonamide | |
3-[[2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-oxoethyl]thio]-6-methyl-2H-1,2,4-triazin-5-one | [no description available] | low | 0 | 0 | sulfonamide | |
N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[4-[2-[3-(dimethylsulfamoyl)anilino]-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-[(4-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-[2-[(2-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
N-(4-methoxyphenyl)-2-[[6-[(4-methylphenyl)sulfonylamino]-4-oxo-1H-pyrimidin-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
mirodenafil | [no description available] | low | 0 | 0 | aromatic ether; N-alkylpiperazine; primary alcohol; pyrrolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
da-8164 | [no description available] | low | 0 | 0 | sulfonamide | |
albendazole | [no description available] | low | 0 | 0 | aryl sulfide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | anthelminthic drug; microtubule-destabilising agent; tubulin modulator |
bendiocarb | [no description available] | low | 0 | 0 | benzodioxoles; carbamate ester | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
bethanechol | [no description available] | low | 0 | 0 | carbamate ester; quaternary ammonium ion | muscarinic agonist |
carbofuran | [no description available] | low | 0 | 0 | 1-benzofurans; carbamate ester | acaricide; agrochemical; avicide; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nematicide |
carisoprodol | [no description available] | low | 0 | 0 | carbamate ester | muscle relaxant |
cefuroxime | [no description available] | low | 0 | 0 | carbamate ester; cephalosporin | |
chlorphenesin carbamate | [no description available] | low | 0 | 0 | carbamate ester; monochlorobenzenes; secondary alcohol | muscle relaxant |
chlorpropham | [no description available] | low | 0 | 0 | benzenes; carbamate ester; monochlorobenzenes | herbicide; plant growth retardant |
distigmine | [no description available] | low | 0 | 0 | carbamate ester; pyridinium ion | EC 3.1.1.8 (cholinesterase) inhibitor; muscarinic agonist |
ethinamate | [no description available] | low | 0 | 0 | carbamate ester; terminal acetylenic compound | sedative |
felbamate | [no description available] | low | 0 | 0 | carbamate ester | anticonvulsant; neuroprotective agent |
fenbendazole | [no description available] | low | 0 | 0 | aryl sulfide; benzimidazoles; carbamate ester | antinematodal drug |
methocarbamol | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester; secondary alcohol | |
methomyl | [no description available] | low | 0 | 0 | aliphatic sulfide; carbamate ester | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; nematicide; xenobiotic |
entinostat | [no description available] | low | 0 | 0 | benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
oxibendazole | [no description available] | low | 0 | 0 | benzimidazoles; carbamate ester | |
phosalone | [no description available] | low | 0 | 0 | 1,3-benzoxazoles; carbamate ester; organochlorine insecticide; organothiophosphate insecticide | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
propoxur | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
1,6-bis(cyclohexyloximinocarbonyl)hexane | [no description available] | low | 0 | 0 | carbamate ester; organonitrogen compound | |
ronidazole | [no description available] | low | 0 | 0 | C-nitro compound; carbamate ester; imidazoles | antiparasitic agent; antiprotozoal drug |
urethane | [no description available] | low | 0 | 0 | carbamate ester | fungal metabolite; mutagen |
ici 204,219 | [no description available] | low | 0 | 0 | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
carbachol | [no description available] | low | 0 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
demecarium | [no description available] | low | 0 | 0 | carbamate ester; quaternary ammonium ion | |
physostigmine | [no description available] | low | 0 | 0 | carbamate ester; indole alkaloid | antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic |
carbaryl | [no description available] | low | 0 | 0 | carbamate ester; naphthalenes | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant growth retardant |
emylcamate | [no description available] | low | 0 | 0 | carbamate ester | |
barban | [no description available] | low | 0 | 0 | acetylenic compound; carbamate ester; monochlorobenzenes | herbicide |
hexapropymate | [no description available] | low | 0 | 0 | carbamate ester | |
diperodon | [no description available] | low | 0 | 0 | carbamate ester | |
uraline | [no description available] | low | 0 | 0 | carbamate ester | |
bethanechol chloride | [no description available] | low | 0 | 0 | carbamate ester; chloride salt; quaternary ammonium salt | muscarinic agonist |
methyl carbamate | [no description available] | low | 0 | 0 | carbamate ester | |
metolcarb | [no description available] | low | 0 | 0 | carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
aminocarb | [no description available] | low | 0 | 0 | carbamate ester; toluenes | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; molluscicide |
methiocarb | [no description available] | low | 0 | 0 | aryl sulfide; carbamate ester; methyl sulfide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; molluscicide; xenobiotic |
mecarbam | [no description available] | low | 0 | 0 | carbamate ester; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
isoprocarb | [no description available] | low | 0 | 0 | carbamate ester | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
methiocarb sulfoxide | [no description available] | low | 0 | 0 | carbamate ester; sulfoxide | marine xenobiotic metabolite |
bpmc | [no description available] | low | 0 | 0 | carbamate ester | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; herbicide; insecticide |
tybamate | [no description available] | low | 0 | 0 | carbamate ester | |
lobendazole | [no description available] | low | 0 | 0 | benzimidazoles; carbamate ester | |
nitrosocarbaryl | [no description available] | low | 0 | 0 | carbamate ester; naphthalenes; nitroso compound | carcinogenic agent; mutagen |
propham | [no description available] | low | 0 | 0 | benzenes; carbamate ester | herbicide; plant growth retardant |
desmedipham | [no description available] | low | 0 | 0 | carbamate ester | agrochemical; environmental contaminant; herbicide; xenobiotic |
phenmedipham | [no description available] | low | 0 | 0 | carbamate ester | environmental contaminant; herbicide; xenobiotic |
carbendazim | [no description available] | low | 0 | 0 | benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | antifungal agrochemical; antinematodal drug; metabolite; microtubule-destabilising agent |
parbendazole | [no description available] | low | 0 | 0 | benzimidazoles; carbamate ester | |
vinyl carbamate | [no description available] | low | 0 | 0 | carbamate ester | |
metergoline | [no description available] | low | 0 | 0 | carbamate ester; ergoline alkaloid | dopamine agonist; geroprotector; serotonergic antagonist |
benomyl | [no description available] | low | 0 | 0 | aromatic amide; benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | acaricide; anthelminthic drug; antifungal agrochemical; microtubule-destabilising agent; tubulin modulator |
carbimazole | [no description available] | low | 0 | 0 | 1,3-dihydroimidazole-2-thiones; carbamate ester | antithyroid drug; prodrug |
formetanate | [no description available] | low | 0 | 0 | carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
pirimicarb | [no description available] | low | 0 | 0 | aminopyrimidine; carbamate ester; tertiary amino compound | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic |
propamocarb | [no description available] | low | 0 | 0 | carbamate ester; carbamate fungicide; tertiary amino compound | antifungal agrochemical; environmental contaminant; xenobiotic |
moricizine | [no description available] | low | 0 | 0 | carbamate ester; morpholines; phenothiazines | anti-arrhythmia drug |
croneton | [no description available] | low | 0 | 0 | carbamate ester | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
flubendazole | [no description available] | low | 0 | 0 | aromatic ketone; benzimidazoles; carbamate ester; organofluorine compound | antinematodal drug; teratogenic agent |
ciclobendazole | [no description available] | low | 0 | 0 | benzimidazoles; carbamate ester | |
oxfendazole | [no description available] | low | 0 | 0 | benzimidazoles; carbamate ester; sulfoxide | antinematodal drug |
dibutylaminosulfenylcarbofuran | [no description available] | low | 0 | 0 | 1-benzofurans; carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide |
diaziquone | [no description available] | low | 0 | 0 | 1,4-benzoquinones; aziridines; carbamate ester; enamine | alkylating agent; antineoplastic agent |
deltanit | [no description available] | low | 0 | 0 | 1-benzofurans; carbamate ester | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
fenoxycarb | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester | environmental contaminant; insecticide; juvenile hormone mimic; xenobiotic |
bambuterol hydrochloride | [no description available] | low | 0 | 0 | carbamate ester; hydrochloride; phenylethanolamines | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; prodrug; sympathomimetic agent |
bambuterol | [no description available] | low | 0 | 0 | carbamate ester; phenylethanolamines | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; prodrug; sympathomimetic agent; tocolytic agent |
benfuracarb | [no description available] | low | 0 | 0 | 1-benzofurans; carbamate ester; ethyl ester | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
irinotecan | [no description available] | low | 0 | 0 | carbamate ester; delta-lactone; N-acylpiperidine; pyranoindolizinoquinoline; ring assembly; tertiary alcohol; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug |
capecitabine | [no description available] | low | 0 | 0 | carbamate ester; cytidines; organofluorine compound | antimetabolite; antineoplastic agent; prodrug |
3-iodo-2-propynylbutylcarbamate | [no description available] | low | 0 | 0 | acetylenic compound; carbamate ester; carbamate fungicide; organoiodine compound | antifungal agrochemical; environmental contaminant; xenobiotic |
cyclarbamate | [no description available] | low | 0 | 0 | carbamate ester | |
carbobenzoxyvalylphenylalanine aldehyde | [no description available] | low | 0 | 0 | aldehyde; carbamate ester; dipeptide | antileishmanial agent; apoptosis inhibitor; EC 3.4.22.52 (calpain-1) inhibitor; EC 3.4.22.53 (calpain-2) inhibitor; EC 3.4.23.46 (memapsin 2) inhibitor |
oxazolidin-2-one | [no description available] | low | 0 | 0 | carbamate ester; oxazolidinone | metabolite |
rivastigmine | [no description available] | low | 0 | 0 | carbamate ester; tertiary amino compound | cholinergic drug; EC 3.1.1.8 (cholinesterase) inhibitor; neuroprotective agent |
diethofencarb | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester; carbanilate fungicide | antifungal agrochemical |
ezogabine | [no description available] | low | 0 | 0 | carbamate ester; organofluorine compound; secondary amino compound; substituted aniline | anticonvulsant; potassium channel modulator |
thiobenzyl benzyloxycarbonyl-l-lysinate | [no description available] | low | 0 | 0 | benzyl ester; carbamate ester; L-lysine derivative; primary amino compound; thiocarboxylic ester | |
torcetrapib | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; carbamate ester; quinolines | anticholesteremic drug; CETP inhibitor |
N-(4-methoxyphenyl)carbamic acid propan-2-yl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-(3-chlorophenyl)carbamic acid 2-pyridinylmethyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-[3-(ethoxycarbonylamino)-2,2-dimethylpropyl]carbamic acid ethyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
nsc-89199 | [no description available] | low | 0 | 0 | carbamate ester; organochlorine compound; steroid phosphate | |
estramustine | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid; carbamate ester; organochlorine compound | alkylating agent; antineoplastic agent; radiation protective agent |
N-(4-fluorophenyl)carbamic acid (2-oxo-1H-pyridin-3-yl) ester | [no description available] | low | 0 | 0 | carbamate ester | |
o-(chloroacetylcarbamoyl)fumagillol | [no description available] | low | 0 | 0 | carbamate ester; organochlorine compound; semisynthetic derivative; sesquiterpenoid; spiro-epoxide | angiogenesis inhibitor; antineoplastic agent; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; methionine aminopeptidase 2 inhibitor; retinoic acid receptor alpha antagonist |
ritonavir | [no description available] | low | 0 | 0 | 1,3-thiazoles; carbamate ester; carboxamide; L-valine derivative; ureas | antiviral drug; environmental contaminant; HIV protease inhibitor; xenobiotic |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde | [no description available] | low | 0 | 0 | amino aldehyde; carbamate ester; tripeptide | proteasome inhibitor |
N-[2-[(3-chloroanilino)-oxomethoxy]ethyl]carbamic acid propan-2-yl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-[4-(2-pyrimidinylsulfamoyl)phenyl]carbamic acid methyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-(4-phenylmethoxyphenyl)carbamic acid methyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-methyl-N-phenylcarbamic acid (4-tert-butylphenyl) ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-(4-chlorophenyl)carbamic acid 2-pyridinylmethyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-(4-chlorophenyl)carbamic acid [1-(4-chlorophenyl)-4-triazolyl]methyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
N-phenylcarbamic acid [5-(2-chlorophenyl)-3-isoxazolyl]methyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
3,3,3-trifluoro-2-hydroxy-2-[4-[methoxycarbonyl(methyl)amino]phenyl]propanoic acid methyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
thiophanate | [no description available] | low | 0 | 0 | benzimidazole precursor fungicide; carbamate ester; carbamate fungicide; thioureas | antifungal agrochemical |
thiophanate | [no description available] | low | 0 | 0 | benzimidazole precursor fungicide; carbamate ester; carbamate fungicide; thioureas | antifungal drug |
maytansine | [no description available] | low | 0 | 0 | alpha-amino acid ester; carbamate ester; epoxide; maytansinoid; organic heterotetracyclic compound; organochlorine compound | antimicrobial agent; antimitotic; antineoplastic agent; plant metabolite; tubulin modulator |
geldanamycin | [no description available] | low | 0 | 0 | 1,4-benzoquinones; ansamycin; carbamate ester; organic heterobicyclic compound | antimicrobial agent; antineoplastic agent; antiviral agent; cysteine protease inhibitor; Hsp90 inhibitor |
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | [no description available] | low | 0 | 0 | 1,4-benzoquinones; ansamycin; carbamate ester; secondary amino compound; tertiary amino compound | Hsp90 inhibitor |
l 685458 | [no description available] | low | 0 | 0 | carbamate ester; monocarboxylic acid amide; peptide; secondary alcohol | EC 3.4.23.46 (memapsin 2) inhibitor; peptidomimetic |
z-val-ala-asp(ome)-fluoromethylketone | [no description available] | low | 0 | 0 | carbamate ester; organofluorine compound; tripeptide | apoptosis inhibitor; protease inhibitor |
pyrachlostrobin | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester; carbanilate fungicide; methoxycarbanilate strobilurin antifungal agent; monochlorobenzenes; pyrazoles | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic |
s 1006 | [no description available] | low | 0 | 0 | 1,3-thiazoles; carbamate ester; carboxylic acid; cephalosporin; enamide; secondary carboxamide | antibacterial drug |
concanamycin a | [no description available] | low | 0 | 0 | carbamate ester; concanamycin | antifungal agent; EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor; metabolite |
kalimantacin a | [no description available] | low | 0 | 0 | alpha,beta-unsaturated monocarboxylic acid; carbamate ester; fatty acid derivative; secondary carboxamide | antibacterial agent; antimicrobial agent; bacterial metabolite |
tanespimycin | [no description available] | low | 0 | 0 | 1,4-benzoquinones; ansamycin; carbamate ester; organic heterobicyclic compound; secondary amino compound | antineoplastic agent; apoptosis inducer; Hsp90 inhibitor |
methiazole | [no description available] | low | 0 | 0 | benzimidazoles; carbamate ester | |
iprovalicarb | [no description available] | low | 0 | 0 | amino acid amide; carbamate ester; valine derivative | |
givinostat | [no description available] | low | 0 | 0 | carbamate ester | |
cay 10499 | [no description available] | low | 0 | 0 | carbamate ester | |
vorapaxar | [no description available] | low | 0 | 0 | carbamate ester; lactone; naphthofuran; organofluorine compound; pyridines | cardiovascular drug; platelet aggregation inhibitor; protease-activated receptor-1 antagonist |
ki16425 | [no description available] | low | 0 | 0 | carbamate ester; isoxazoles; monocarboxylic acid; monochlorobenzenes; organic sulfide | |
tedizolid | [no description available] | low | 0 | 0 | carbamate ester; organofluorine compound; oxazolidinone; primary alcohol; pyridines; tetrazoles | antimicrobial agent; drug metabolite; protein synthesis inhibitor |
bay 63-2521 | [no description available] | low | 0 | 0 | aminopyrimidine; carbamate ester; organofluorine compound; pyrazolopyridine | antihypertensive agent; soluble guanylate cyclase activator |
tedizolid phosphate | [no description available] | low | 0 | 0 | carbamate ester; organofluorine compound; oxazolidinone; phosphate monoester; pyridines; tetrazoles | antimicrobial agent; prodrug; protein synthesis inhibitor |
bay 60-4552 | [no description available] | low | 0 | 0 | aminopyrimidine; carbamate ester; monofluorobenzenes; pyrazolopyridine | antihypertensive agent; drug metabolite; soluble guanylate cyclase activator; vasodilator agent |
wyosine | [no description available] | low | 0 | 0 | carbamate ester; methyl ester; nucleoside analogue | |
mk-7009 | [no description available] | low | 0 | 0 | azamacrocycle; carbamate ester; cyclopropanes; N-sulfonylcarboxamide; pyrrolidinecarboxamide | antiviral drug; hepatitis C protease inhibitor |
N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
cobicistat | [no description available] | low | 0 | 0 | 1,3-thiazoles; carbamate ester; monocarboxylic acid amide; morpholines; ureas | P450 inhibitor |
bms-790052 | [no description available] | low | 0 | 0 | biphenyls; carbamate ester; carboxamide; imidazoles; valine derivative | antiviral drug; nonstructural protein 5A inhibitor |
4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | carbamate ester | |
grazoprevir | [no description available] | low | 0 | 0 | aromatic ether; azamacrocycle; carbamate ester; cyclopropanes; lactam; N-sulfonylcarboxamide; quinoxaline derivative | antiviral drug; hepatitis C protease inhibitor; hepatoprotective agent |
vericiguat | [no description available] | low | 0 | 0 | aminopyrimidine; carbamate ester; organofluorine compound; pyrazolopyridine | antihypertensive agent; soluble guanylate cyclase activator; vasodilator agent |
novobiocin | [no description available] | low | 0 | 0 | carbamate ester; ether; hexoside; hydroxycoumarin; monocarboxylic acid amide; monosaccharide derivative; phenols | antibacterial agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Escherichia coli metabolite; hepatoprotective agent |
abt-267 | [no description available] | low | 0 | 0 | aromatic amide; carbamate ester; dipeptide; pyrrolidines | antiviral drug; hepatitis C virus nonstructural protein 5A inhibitor |
saxitoxin | [no description available] | low | 0 | 0 | alkaloid; carbamate ester; guanidines; ketone hydrate; paralytic shellfish toxin; pyrrolopurine | cyanotoxin; marine metabolite; neurotoxin; sodium channel blocker; toxin |
ledipasvir | [no description available] | low | 0 | 0 | azaspiro compound; benzimidazole; bridged compound; carbamate ester; carboxamide; fluorenes; imidazoles; L-valine derivative; N-acylpyrrolidine; organofluorine compound | antiviral drug; hepatitis C protease inhibitor |
gs-5816 | [no description available] | low | 0 | 0 | carbamate ester; ether; imidazoles; L-valine derivative; N-acylpyrrolidine; organic heteropentacyclic compound; ring assembly | antiviral drug; hepatitis C virus nonstructural protein 5A inhibitor |
mk-8742 | [no description available] | low | 0 | 0 | carbamate ester; imidazoles; L-valine derivative; N-acylpyrrolidine; organic heterotetracyclic compound; ring assembly | antiviral drug; hepatitis C virus nonstructural protein 5A inhibitor; hepatoprotective agent |
Condition | Indicated | Relationship Strength | Studies | Trials |
---|---|---|---|---|
Inflammation | 0 | low | 1 | 0 |
Innate Inflammatory Response | 0 | low | 1 | 0 |
Malaria, Falciparum | 0 | low | 1 | 0 |
Plasmodium falciparum Malaria | 0 | low | 1 | 0 |